Health Sciences International, based in Connecticut, aims to conduct quality phase I-IV trial research with key therapeutic areas of focus including cardiology, vascular disorders, CNS, endocrinology and internal medicine. The organization has participated in around 100 clinical trials, offering clients consulting services that include R&D expertise, statistical analysis plan development, project and data management, quality enforcement and team building.
Kansas-based PRL Central Laboratory Services specializes in diagnostic testing, focusing on protocol requirements. It has worked with clinical service providers like BioClinica, ensuring timely results and validated data management for customers.
BioClinica claimed that both alliances bolster its Certified Partner Program, a group of VIP CRO partners chosen based on customer satisfaction and therapeutic know-how.
Mark Weinstein, CEO of BioClinica, said: “We are proud to partner with Health Sciences International and PRL Central Laboratory Services, expanding upon the dozens of CRO partnerships held by BioClinica worldwide. Our newest partners demonstrate the quality and continued growth of the BioClinica Certified Partner Program.
“Till date our certified partners represent a collective experience of more than 700 trials in more than 6,000 sites across 52 countries. This program is one more way that BioClinica provides best-in-class resources for customers.”